| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |